Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Condition(s):Malignant ThymomaLast Updated:February 6, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Malignant ThymomaLast Updated:February 6, 2019Terminated
Condition(s):Recurrent Malignant Thymoma; ThymomaLast Updated:September 21, 2023Active, not recruiting
Condition(s):Primary Inoperable Thymoma; Local Recurrent ThymomaLast Updated:February 5, 2018Completed
Condition(s):Thymoma; Thymic Carcinoma; Thymic Carcinoid; Thymic Neuroendocrine TumorsLast Updated:December 23, 2016Completed
Condition(s):Thymic Epithelial Tumor; Recurrent Thymoma; Thymic CancerLast Updated:February 6, 2024Recruiting
Condition(s):ThymomaLast Updated:April 11, 2022Completed
Condition(s):Thymoma; Masaoka Stage I; Masaoka Stage IILast Updated:September 19, 2022Completed
Condition(s):Thymoma; Thymic CarcinomaLast Updated:September 30, 2015Completed
Condition(s):Thymoma; Thymic Carcinoma; Clinical Masaoka Stage II to IVALast Updated:May 31, 2023Active, not recruiting
Condition(s):Thymic Cancer; ThymomaLast Updated:June 3, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.